Back

Analysts maintain bullish ratings on Moleculin Biotech and Alphabet

Verifying
  • Maxim Group maintained a Buy rating on Moleculin Biotech and set a $2.00 price target.
  • Moleculin shares closed at $0.50, near their 52-week low of $0.40.
  • Evercore ISI maintained a Buy rating on Alphabet Class A, according to the report.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Analysts maintain bullish ratings on Moleculin Biotech and Alphabet - CoinPost Terminal